This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Tianjin Hongri Jian Da Kang Medical Technology Co., Ltd. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Xinying Zhao: Innovator in Sulfonamide Pharmaceutical Composition
Introduction
Xinying Zhao is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on sulfonamide compounds. His research and inventions have the potential to impact medical treatments and improve patient care.
Latest Patents
Xinying Zhao holds a patent for a sulfonamide pharmaceutical composition. This invention relates to an injectable preparation that comprises a sulfonamide compound or a derivative thereof. The injectable preparation is created using a sulfonamide compound and a pharmaceutically acceptable carrier through specific preparation technologies. The resulting sulfonamide compound injectable preparation is noted for its stability, quality control, and effectiveness.
Career Highlights
Throughout his career, Xinying Zhao has worked with various companies, including Tianjin Hongri Jian Da Kang Medical Technology Co., Ltd and Huawei Digital Power Technologies Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations
Xinying Zhao has collaborated with several professionals in his field, including Yi Juang Wu and Changhai Sun. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Xinying Zhao is a prominent inventor whose work in sulfonamide pharmaceutical compositions showcases his dedication to improving medical treatments. His innovative contributions and collaborations highlight the importance of research and development in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile